A molecular role for lysyl oxidase in breast cancer invasion - PubMed (original) (raw)
. 2002 Aug 1;62(15):4478-83.
Affiliations
- PMID: 12154058
A molecular role for lysyl oxidase in breast cancer invasion
Dawn A Kirschmann et al. Cancer Res. 2002.
Abstract
We identified previously an up-regulation in lysyl oxidase (LOX) expression,an extracellular matrix remodeling enzyme, in a highly invasive/metastatic human breast cancer cell line, MDA-MB-231, compared with MCF-7, a poorly invasive/nonmetastatic breast cancer cell line. In this study, we demonstrate that the mRNA expression of LOX and other LOX family members [lysyl oxidase-like (LOXL), LOXL2, LOXL3, and LOXL4] was observed only in breast cancer cells with a highly invasive/metastatic phenotype but not in poorly invasive/nonmetastatic breast cancer cells. LOX and LOXL2 showed the strongest association with invasive potential in both highly invasive/metastatic breast cancer cell lines tested (MDA-MB-231 and Hs578T). To determine whether LOX is directly involved in breast cancer invasion, LOX antisense oligonucleotides were transfected into MDA-MB-231 and Hs578T cells, and found to inhibit invasion through a collagen IV/laminin/gelatin matrix in vitro compared with LOX sense oligonucleotide-treated and untreated controls. In addition, treatment of MDA-MB-231 and Hs578T cells with beta-aminopropionitrile (an irreversible inhibitor of LOX enzymatic activity) decreased invasive activity. Conversely, MCF-7 cells transfected with the murine LOX gene demonstrated a 2-fold increase in invasiveness that was reversible by the addition of beta-aminopropionitrile in a dose-dependent manner. In addition, endogenous LOX mRNA expression was induced when MCF-7 cells were cultured in the presence of fibroblast conditioned medium or conditioned matrix, suggesting a role for stromal fibroblasts in LOX regulation in breast cancer cells. Moreover, the correlation of LOX up-regulation and invasive/metastatic potential was additionally demonstrated in rat prostatic tumor cell lines, and human cutaneous and uveal melanoma cell lines. These results provide substantial new evidence that LOX is involved in cancer cell invasion.
Similar articles
- Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ, Kirschmann DA. Payne SL, et al. Cancer Res. 2005 Dec 15;65(24):11429-36. doi: 10.1158/0008-5472.CAN-05-1274. Cancer Res. 2005. PMID: 16357151 - Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM, Abbott DE, Payne SL, Wheaton WW, Margaryan NV, Sullivan R, Jansen MK, Csiszar K, Hendrix MJ, Kirschmann DA. Postovit LM, et al. J Cell Biochem. 2008 Apr 1;103(5):1369-78. doi: 10.1002/jcb.21517. J Cell Biochem. 2008. PMID: 17685448 - Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS. Chen LC, et al. Breast Cancer Res Treat. 2012 Aug;134(3):989-1004. doi: 10.1007/s10549-012-1986-8. Epub 2012 Mar 21. Breast Cancer Res Treat. 2012. PMID: 22434522 - Paradoxical roles for lysyl oxidases in cancer--a prospect.
Payne SL, Hendrix MJ, Kirschmann DA. Payne SL, et al. J Cell Biochem. 2007 Aug 15;101(6):1338-54. doi: 10.1002/jcb.21371. J Cell Biochem. 2007. PMID: 17471532 Review. - Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas.
Decitre M, Gleyzal C, Raccurt M, Peyrol S, Aubert-Foucher E, Csiszar K, Sommer P. Decitre M, et al. Lab Invest. 1998 Feb;78(2):143-51. Lab Invest. 1998. PMID: 9484712 Review.
Cited by
- Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis.
Baker AM, Bird D, Welti JC, Gourlaouen M, Lang G, Murray GI, Reynolds AR, Cox TR, Erler JT. Baker AM, et al. Cancer Res. 2013 Jan 15;73(2):583-94. doi: 10.1158/0008-5472.CAN-12-2447. Epub 2012 Nov 27. Cancer Res. 2013. PMID: 23188504 Free PMC article. - _O_2-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation.
Kang F, Zhu J, Wu J, Lv T, Xiang H, Tian J, Zhang Y, Huang Z. Kang F, et al. Chem Sci. 2018 Aug 3;9(34):6893-6898. doi: 10.1039/c8sc00167g. eCollection 2018 Sep 14. Chem Sci. 2018. PMID: 30210764 Free PMC article. - Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
Wu S, Zheng Q, Xing X, Dong Y, Wang Y, You Y, Chen R, Hu C, Chen J, Gao D, Zhao Y, Wang Z, Xue T, Ren Z, Cui J. Wu S, et al. J Exp Clin Cancer Res. 2018 May 4;37(1):99. doi: 10.1186/s13046-018-0761-z. J Exp Clin Cancer Res. 2018. PMID: 29728125 Free PMC article. - Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA, Amin JD, Kirschmann DA, Schiemann WP. Taylor MA, et al. Neoplasia. 2011 May;13(5):406-18. doi: 10.1593/neo.101086. Neoplasia. 2011. PMID: 21532881 Free PMC article. - A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.
Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, Trackman PC, Spicer DB, Rosenberg L, Palmer JR, Sonenshein GE. Min C, et al. Cancer Res. 2009 Aug 15;69(16):6685-93. doi: 10.1158/0008-5472.CAN-08-4818. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654310 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous